Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€104.86
16.08.22
-
16.08.23
-6.73%
16.08.23

buy
Cross Country Healthcare

Start price
Target price
Perf. (%)
€21.40
16.08.22
-
16.08.23
0.93%
16.08.23

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.03
16.08.22
-
16.08.23
-11.99%
16.08.23

buy
Altimmune

Start price
Target price
Perf. (%)
€16.61
16.08.22
-
16.08.23
-84.35%
16.08.23

buy
Sunopta Inc.

Start price
Target price
Perf. (%)
€11.18
16.08.22
-
16.08.23
-62.36%
16.08.23

buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€239.10
15.08.22
-
15.08.23
46.68%
15.08.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Top Rating
Very capable Management
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€165.90
15.08.22
€180.00
31.01.24
9.64%
08.05.23

Could be very worthwhile Investment >20% year
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€165.90
15.08.22
€180.00
31.01.24
9.64%
08.05.23

Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.91
13.08.22
€1.00
13.08.23
-12.70%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.97
13.08.22
€5.00
13.08.23
-6.09%
04.09.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Redhill Biopharma Ltd ADR

Start price
Target price
Perf. (%)
€1.06
13.08.22
€7.20
13.08.23
-13.55%
23.08.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.97
13.08.22
€14.00
13.08.23
1.02%
22.08.22

Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€48.30
12.08.22
€55.00
12.08.23
-17.99%
13.08.23

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€48.30
12.08.22
€55.00
12.08.23
-17.99%
13.08.23

buy
Synlab AG

Start price
Target price
Perf. (%)
€15.90
12.08.22
€19.00
12.08.23
-41.51%
13.08.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Zebra Technologies A

Start price
Target price
Perf. (%)
€329.50
12.08.22
€380.00
12.08.23
-26.86%
13.08.23

buy
Zebra Technologies A

Start price
Target price
Perf. (%)
€329.50
12.08.22
€380.00
12.08.23
-26.86%
13.08.23

buy
Vicor Corp.

Start price
Target price
Perf. (%)
€74.50
12.08.22
€86.00
12.08.23
-8.72%
13.08.23

buy
RCI Hospitality Holdings Inc

Start price
Target price
Perf. (%)
€69.50
12.08.22
€80.00
12.08.23
-12.23%
13.08.23

buy
BASF SE

Start price
Target price
Perf. (%)
€43.97
12.08.22
-
12.09.22
2.63%
13.09.22

Could be very worthwhile Investment >20% year
buy
BASF SE

Start price
Target price
Perf. (%)
€43.97
12.08.22
-
12.09.22
2.63%
13.09.22

Could be very worthwhile Investment >20% year
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€115.08
12.08.22
€125.00
12.08.23
5.79%
16.08.22

EBIT growth > 30% per year expected
Undervalued
Very high dividend yield expected
Top Rating
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€115.08
12.08.22
€125.00
12.08.23
5.79%
16.08.22

EBIT growth > 30% per year expected
Undervalued
Very high dividend yield expected
Top Rating
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€114.76
12.08.22
€88.00
12.08.23
-29.42%
12.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
High dividend yield expected
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€114.76
12.08.22
€88.00
12.08.23
-29.42%
12.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
High dividend yield expected